| Item Type | Name |
|
Concept
|
Cisplatin
|
|
Academic Article
|
Platinum/etoposide therapy in non-small cell lung cancer.
|
|
Academic Article
|
Recent advances in etoposide therapy for non-small cell lung cancer.
|
|
Academic Article
|
Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.
|
|
Academic Article
|
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
|
|
Academic Article
|
Neoadjuvant treatment in locally advanced non-small cell lung cancer.
|
|
Academic Article
|
Combined modality therapy for locally advanced non-small cell lung carcinoma.
|
|
Academic Article
|
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
|
|
Academic Article
|
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
|
|
Academic Article
|
A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
|
|
Academic Article
|
Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma.
|
|
Academic Article
|
Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancer.
|
|
Academic Article
|
Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
|
|
Academic Article
|
Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.
|
|
Academic Article
|
Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer.
|
|
Academic Article
|
Modification of the effects of cytotoxic chemotherapy on the immune responses of cancer patients with a nonsteroidal, antiinflammatory drug, piroxicam. A pilot study of the Eastern Cooperative Oncology Group.
|
|
Academic Article
|
Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
|
|
Academic Article
|
Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma.
|
|
Academic Article
|
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
|
|
Academic Article
|
Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
|
|
Academic Article
|
Combined modality treatment for stage III non-small cell lung cancer.
|
|
Academic Article
|
Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
|
|
Academic Article
|
Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study.
|
|
Academic Article
|
Radiation and simultaneous cisplatin in non-small cell lung cancer.
|
|
Academic Article
|
EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
|
|
Academic Article
|
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
|
|
Academic Article
|
Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
|
|
Academic Article
|
Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer.
|
|
Academic Article
|
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.
|
|
Academic Article
|
A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
|
|
Academic Article
|
Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
|
|
Academic Article
|
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
|
|
Academic Article
|
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
|
|
Academic Article
|
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
|
|
Academic Article
|
Chemoradiation in locally advanced non-small cell lung cancer.
|
|
Academic Article
|
Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
|
|
Academic Article
|
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.
|
|
Academic Article
|
Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.
|
|
Academic Article
|
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.
|